Physician profile
Benjamin C Pinner
NPI 1497856371
$18,113.10
in general payments reported to CMS, 2019-2025
79 companies · $2,521 in 2025
The $2,521 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,376 · 2020: $2,222 · 2021: $3,291 · 2022: $2,811 · 2023: $2,476 · 2024: $2,415 · 2025: $2,521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,249 · Gift: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,248.72 |
| Gift | $163.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,386.18 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Abbvie INC. | $1,384.78 | 2020-2025 | |
| Novo Nordisk INC | $1,375.52 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $860.31 | 2019-2025 | Repatha, Otezla, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $810.88 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $760.22 | 2019-2025 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $716.82 | 2019-2025 | Trintellix |
| Lilly USA, LLC | $708.81 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $643.61 | 2019-2025 | |
| Braintree Laboratories, INC. | $636.36 | 2019-2025 | Sutab |
| Otsuka America Pharmaceutical, INC. | $567.98 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $560.83 | 2019-2024 | Jardiance |
| Amarin Pharma, INC. | $550.89 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $518.24 | 2019-2025 | |
| Glaxosmithkline, LLC. | $433.72 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
Show all 79 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $355.14 | 2019-2023 | |
| Xeris Pharmaceuticals, INC. | $340.05 | 2022-2025 | Recorlev, Gvoke Hypopen |
| Merz North America, INC. | $338.78 | 2019 | |
| Corcept Therapeutics | $336.15 | 2021-2025 | Korlym |
| Axsome Therapeutics, INC. | $323.74 | 2023-2025 | Sunosi, Auvelity |
| Esperion Therapeutics, INC. | $319.85 | 2020-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $245.96 | 2024-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $228.83 | 2019-2025 | Verquvo, Capvaxive |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $221.45 | 2022-2025 | Caplyta |
| Abbott Laboratories | $202.79 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $189.99 | 2019-2022 | |
| Lundbeck LLC | $173.83 | 2020-2025 | Rexulti, Vyepti |
| Kowa Pharmaceuticals America, INC. | $167.68 | 2020-2025 | Zoryve |
| Dexcom, INC. | $165.87 | 2023-2025 | Dexcom G6 Transmitter |
| Arbor Pharmaceuticals, INC. | $162.06 | 2019-2022 | |
| Eisai INC. | $159.74 | 2020-2021 | |
| Ardelyx, INC. | $149.73 | 2024-2025 | Ibsrela |
| Smith+Nephew, INC. | $149.37 | 2019 | |
| Allergan, INC. | $147.60 | 2019-2020 | |
| Exact Sciences Corporation | $136.50 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceuticals, INC. | $125.40 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $117.66 | 2022 | |
| Mylan Specialty L.P. | $108.70 | 2019-2022 | |
| Astellas Pharma US INC | $102.59 | 2019-2025 | Veozah |
| Forte Bio-Pharma LLC | $87.16 | 2020-2022 | |
| Daiichi Sankyo INC. | $82.88 | 2020-2023 | Injectafer |
| Ironwood Pharmaceuticals, INC | $71.74 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $61.68 | 2020-2025 | Fanapt, Hetlioz |
| Nestle Healthcare Nutrition INC. | $61.20 | 2021 | |
| Shield Therapeutics INC | $52.61 | 2024-2025 | |
| Insulet Corporation | $50.36 | 2021 | |
| Medtronic, INC. | $49.49 | 2023-2024 | Intellis Adaptivestim |
| Azurity Pharmaceuticals, INC. | $48.94 | 2024-2025 | Horizant, Azmiro, Alvesco |
| Supernus Pharmaceuticals, INC. | $46.83 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $46.48 | 2024-2025 | Voquezna |
| Impel Pharmaceuticals INC. | $42.57 | 2023 | Trudhesa |
| Antares Pharma, INC. | $42.40 | 2024 | Xyosted |
| Genzyme Corporation | $33.96 | 2024 | |
| Sanofi Pasteur INC. | $32.73 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $27.75 | 2019-2021 | |
| Boston Scientific Corporation | $25.01 | 2023 | Wavewriter Alpha Prime 16 |
| Jazz Pharmaceuticals INC. | $24.85 | 2021 | |
| Biogen, INC. | $23.28 | 2021 | |
| Stryker Corporation | $21.93 | 2025 | Clottriever Bold Catheter |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Vivus LLC | $20.18 | 2020 | |
| Genentech USA, INC. | $18.88 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $18.76 | 2022 | |
| Tris Pharma INC | $18.49 | 2024 | Dyanavel Xr |
| Sunovion Pharmaceuticals INC. | $17.03 | 2020 | |
| Alnylam Pharmaceuticals INC. | $16.92 | 2022 | |
| Inari Medical, INC. | $14.84 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ultragenyx Pharmaceutical INC. | $13.94 | 2021 | |
| Intuity Medical INC | $13.42 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Medicure Pharma INC. | $13.40 | 2022 | |
| Galderma Laboratories, L.P. | $13.26 | 2024 | |
| Scynexis, INC. | $13.15 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.83 | 2023 | Quviviq |
| Seqirus USA INC | $12.68 | 2022 | |
| Acerus Pharmaceuticals Corporation | $12.51 | 2022 | |
| Organon LLC | $11.99 | 2025 | Nexplanon |
| Assertio Therapeutics, INC. | $11.45 | 2020 | |
| Alfasigma USA, INC. | $11.10 | 2021 | |
| Clarus Therapeutics INC. | $8.81 | 2021 |
Drugs and devices associated with these payments
Rexulti $502Breztri $486Farxiga $460Ozempic $378Vraylar $377Airsupra $360Kerendia $345Leqvio $301Rybelsus $295Nurtec Odt $288Jardiance $269Recorlev $250Gemtesa $246Xifaxan $244Sunosi $231Trintellix $227Ubrelvy $219Qulipta $196Mounjaro $174Dexcom G6 Transmitter $166Wegovy $165Sutab $164Korlym $159Shingrix $154Ibsrela $150Paxlovid $135Eliquis $132Caplyta $130Trelegy Ellipta $124Entresto $122Comirnaty $116Zoryve $106Arexvy $103Repatha $103Prevnar 20 $99.62Abrysvo $99.62Nexletol $96.96Auvelity $92.76Otezla $89.02Cologuard Collection Kit $80.79Verquvo $73.27Gvoke Hypopen $72.03Veozah $68.74The Cologuard Plus Collection Kit $55.71Accrufer $52.61Emgality $49.62Intellis Adaptivestim $49.49Zavzpret $48.90Voquezna $46.48Hetlioz $46.45Fanapt $46.45Trulance $42.70Trudhesa $42.57Xyosted $42.40Dupixent $33.96Fluzone Quadrivalent Northern Hemisphere $32.73Fluzone High-Dose $32.73Flublok Quadrivalent Northern Hemisphere $32.73Evenity $30.66Prolia $30.66Creon $28.35Zepbound $27.48Vyepti $27.24Wavewriter Alpha Prime 16 $25.01Thoratec Heartmate 3 Lvas Implant Kit $24.99Soliqua 100/33 $23.34Clottriever Bold Catheter $21.93Beyfortus $18.53Dyanavel Xr $18.49Horizant $17.86Azmiro $16.58Injectafer $16.35Flowtriever Catheter, S $14.84Ct Thrombectomy System Kit $14.84Alvesco $14.50Capvaxive $13.68Pogo Automatic Blood Glucose Monitoring System $13.42Quviviq $12.83Nexplanon $11.99Viberzi $4.14Linzess $4.14
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Pinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.